Alcohol consumption poses a significant global health risk, contributing to numerous diseases and injuries, especially among ...

Strategic insight into the Liver Cancer Treatment Market reveals a high-growth opportunity, especially in Asia-Pacific, driven by a rising patient po ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

ACG released new guidance for the management of malnutrition in patients with liver disease, including the newly renamed ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

MASLD is a condition where excess fat accumulates in the liver of individuals who consume little to no alcohol.

Hepatocellular carcinoma (HCC) is a common malignant tumor and the third leading cause of cancer-related mortality. The lack ...

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.